Lannett Company, Inc. | Business Contracts

Certificate of Amendment to the Certificate of Incorporation of Lannett Company, Inc (Filed With SEC on February 7, 2023)

Form of Retention Award Letter (Filed With SEC on August 25, 2022)

Manufacture and Supply Agreement by and between Chartwell Pharmaceuticals Carmel, LLC, Chartwell Pharmaceuticals LLC, and Lannett Company, Inc (Filed With SEC on May 10, 2022)

Asset Purchase Agreement by and between Chartwell Carmel Assets, LLC, Chartwell Pharmaceuticals LLC, Silarx Pharmaceuticals, Inc., Lannett Company, Inc., and Lannett Holdings, Inc (Filed With SEC on May 10, 2022)

Amendment No. 1 to License and Supply Agreement between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) and Kremers Urban Pharmaceuticals, Inc (Filed With SEC on February 4, 2021)

Sublicense Agreement between Lannett Company, Inc. and Ypsomed AG (Filed With SEC on February 2, 2023)

Contract of Sale-Office, Commercial and Multi-Family Residential Premises between Silarx Pharmaceuticals, Inc. and Chartwell Carmel Realty, LLC (Filed With SEC on May 10, 2022)

Fourth Amendment to Restated Employment Agreement of John Kozlowski (Filed With SEC on January 20, 2022)

Fourth Addendum to Employment Agreement of Timothy Crew (Filed With SEC on January 20, 2022)

Third Addendum to Employment Agreement of Maureen Cavanaugh (Filed With SEC on January 20, 2022)

Third Addendum to Employment Agreement of Samuel H. Israel (Filed With SEC on January 20, 2022)

Third Addendum to Employment Agreement of John Abt (Filed With SEC on January 20, 2022)

Amendment No. 1 to Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Filed With SEC on August 26, 2021)

Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Filed With SEC on August 26, 2021)

Supply Agreement by and among Lannett Company, Inc. and Sunshine Lake Pharma Co., Ltd (Filed With SEC on May 6, 2021)

Collaboration and License Agreement by and among Lannett Company, Inc. and Sunshine Lake Pharma Co., Ltd (Filed With SEC on May 6, 2021)

Amended and Restated Exchange Agreement dated April 8, 2021, among Lannett Company, Inc. and the participating lenders party thereto (Filed With SEC on April 12, 2021)

Exchange Agreement dated April 5, 2021, among Lannett Company, Inc. and the participating lenders party thereto (Filed With SEC on April 6, 2021)

Amendment No. 2 to License and Supply Agreement between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) and Kremers Urban Pharmaceuticals, Inc (Filed With SEC on February 4, 2021)

License and Supply Agreement with Alkermes Pharma Ireland Limited and Kremers Urban Pharmaceuticals Inc (Filed With SEC on February 4, 2021)

Fourth Addendum to Employment Agreement of Timothy C. Crew dated December 28, 2020 (Filed With SEC on December 29, 2020)

Second Addendum to Amended and Restated Employment Agreement of Robert Ehlinger (Filed With SEC on August 28, 2020)

Second Addendum to Employment Agreement of John Abt (Filed With SEC on August 28, 2020)

Second Addendum to Employment Agreement of Samuel H. Israel (Filed With SEC on August 28, 2020)

Second Addendum to Employment Agreement of Maureen Cavanaugh (Filed With SEC on August 28, 2020)

Third Amendment to Restated Employment Agreement of John Kozlowski (Filed With SEC on August 28, 2020)

Third Addendum to Employment Agreement of Timothy Crew (Filed With SEC on August 28, 2020)

Amendment to Sinotherapeutics Distribution and Supply Agreement (Filed With SEC on August 27, 2020)

Supply Agreement by and among North & South Brother Pharmacy Investment Co., Ltd, HEC GROUP PTY LTD and Lannett Company, Inc., dated as of November 21, 2019 (Filed With SEC on February 6, 2020)

Collaboration and License Agreement by and among Lannett Company, Inc., North & South Brother Pharmacy Investment Co., Ltd and HEC GROUP PTY LTD, dated as of November 21, 2019 (Filed With SEC on February 6, 2020)

Lannett Company, Inc. Non-Qualified Deferred Compensation Plan (Filed With SEC on November 7, 2019)

Sinotherapeutics Distribution and Supply Agreement (Filed With SEC on November 7, 2019)

Cediprof Agreement (Filed With SEC on November 7, 2019)

Indenture, dated as of September 27, 2019, between the Company and Wilmington Trust, National Association, as trustee (including form of 4.50% Convertible Senior Notes due 2026) (Filed With SEC on September 27, 2019)

Form of Capped Call Confirmations (Filed With SEC on September 27, 2019)

Description of Capital Stock of Lannett Company, Inc (Filed With SEC on August 28, 2019)

Second Amendment to Restated Employment Agreement of John Kozlowski, dated as of July 31, 2019 (Filed With SEC on August 1, 2019)

Separation Agreement and General Release by and between Martin Galvan and Lannett Company, Inc. dated May 22, 2019 (Filed With SEC on May 24, 2019)

Amneal Distribution and Transition Support Agreement (Filed With SEC on February 7, 2019)

Lannett Company, Inc. (39)